TREM-1 inhibiting SCHOOL peptides (SignaBlok)

N/A

Report date: 2025/01/26 15:39:44

Base Information

Drug NameTREM-1 inhibiting SCHOOL peptides (SignaBlok)
Drug Alias NameTREM-1 inhibiting SCHOOL peptides (SignaBlok)triggering receptor expressed on myeloid cells-1 inhibitors (SignaBlok)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTriggering receptor expressed on myeloid cells 1 inhibitors
TargetsTriggering receptor expressed on myeloid cells 1
Therapy Area/IndicationsShock, HemorrhagicCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignaBlok Inc
China Registration ClassN/A

Develop Information

Active CompaniesSignaBlok Inc
Inactive CompaniesN/A
Active IndicationsShock, HemorrhagicCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A